The once-weekly injection, already approved in pediatric patients with GHD, offers convenience over daily injections.

Jacob Sands, MD, discusses the data that support the FDA accelerated approval of Dato-DXd in EGFR-positive non–small cell ...

Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A ...

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

Starting August 14, 2025, Wildtype’s cultivated salmon will be featured on the menu at Robin, a San Francisco restaurant led ...

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...

The U.S. Food and Drug Administration has approved Sephience (sepiapterin), an oral therapy by PTC Therapeutics, for the ...

After our editorial, the agency relents to allow a Duchenne treatment.

Vinay Prasad had come under fire from some Republicans and conservative activists, including far-right activist Laura Loomer, ...